Human spamolytic polypeptide in glycosylated form
OwnerLars Thim, Kjeld Norris +4inventors
InventorsLars Thim, Kjeld Norris, Fanny Norris, Soren Bjorn, Mogens Christensen, Per Franklin Nielsen
Life of this patent
Estimating the term…
Abstract
A human spasmolytic polypeptide (HSP) having the amino acid SEQ ID NO:1, characterized by being in a glycosylated form.
Claims26
Human spasmolytic polypeptide (HSP) which has the amino acid sequence
- 6 (SEQ ID NO:1) Glu Lys Pro Ser Pro Cys Gln Cys Ser Arg Leu Ser Pro His Asn Arg Thr Asn Cys Gly Phe Pro Gly Ile Thr Ser Asp Gln Cys Phe Asp Asn Gly Cys Cys Phe Asp Ser Ser Val Thr Gly Val Pro Trp Cys Phe His Pro Leu Pro Lys Gln Glu Ser Asp Gln Cys Val Met Glu Val Ser Asp Arg Arg Asn Cys Gly Tyr Pro Gly Ile Ser Pro Glu Glu Cys Ala Ser Arg Lys Cys Cys Phe Ser Asn Phe Ile Phe Glu Val Pro Trp Cys Phe Phe Pro Asn Ser Val Glu Asp Cys His Tyr
- or a functionally equivalent homologue thereof, characterized by being in glycosylated form.
A variant of a spasmolytic polypeptide which is a fragment of human spasmolytic polypeptide (HSP) or porcine spasmolytic polypeptide (PSP) comprising at least one trefoil domain.
A method of preparing a spasmolytic polypeptide in at least 60% glycosylated form, wherein a host cell transformed with a DNA fragment encoding a spasmolytic polypeptide and capable of providing glycosylation of said spasmolytic polypeptide is cultured under conditions permitting production of said spasmolytic polypeptide and recovering the resulting spasmolytic polypeptide from the culture.
Dependencies are inferred from the claim text.